164 related articles for article (PubMed ID: 12011470)
1. Anticonvulsant activity of a nonpeptide galanin receptor agonist.
Saar K; Mazarati AM; Mahlapuu R; Hallnemo G; Soomets U; Kilk K; Hellberg S; Pooga M; Tolf BR; Shi TS; Hökfelt T; Wasterlain C; Bartfai T; Langel U
Proc Natl Acad Sci U S A; 2002 May; 99(10):7136-41. PubMed ID: 12011470
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
[TBL] [Abstract][Full Text] [Related]
3. Regulation of feeding by galnon.
Abramov U; Florén A; Echevarria DJ; Brewer A; Manuzon H; Robinson JK; Bartfai T; Vasar E; Langel U
Neuropeptides; 2004 Feb; 38(1):55-61. PubMed ID: 15003717
[TBL] [Abstract][Full Text] [Related]
4. Galnon--a low-molecular weight ligand of the galanin receptors.
Sollenberg U; Bartfai T; Langel U
Neuropeptides; 2005 Jun; 39(3):161-3. PubMed ID: 15944006
[TBL] [Abstract][Full Text] [Related]
5. Effect of galnon on induction of long-term potentiation in dentate gyrus of C57BL/6 mice.
Badie-Mahdavi H; Behrens MM; Rebek J; Bartfai T
Neuropeptides; 2005 Jun; 39(3):249-51. PubMed ID: 15944018
[TBL] [Abstract][Full Text] [Related]
6. Effects of galnon, a non-peptide galanin-receptor agonist, on insulin release from rat pancreatic islets.
Quynh NT; Islam MS; Florén A; Bartfai T; Langel U; Ostenson CG
Biochem Biophys Res Commun; 2005 Mar; 328(1):213-20. PubMed ID: 15670772
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of galmic: a nonpeptide galanin receptor agonist.
Ceide SC; Trembleau L; Haberhauer G; Somogyi L; Lu X; Bartfai T; Rebek J
Proc Natl Acad Sci U S A; 2004 Nov; 101(48):16727-32. PubMed ID: 15557002
[TBL] [Abstract][Full Text] [Related]
8. Systemic galnon, a low-molecular weight galanin receptor agonist, reduces heat hyperalgesia in rats with nerve injury.
Wu WP; Hao JX; Lundström L; Wiesenfeld-Hallin Z; Langel U; Bartfai T; Xu XJ
Eur J Pharmacol; 2003 Dec; 482(1-3):133-7. PubMed ID: 14660014
[TBL] [Abstract][Full Text] [Related]
9. Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors.
Mazarati A; Lu X
Neuropeptides; 2005 Jun; 39(3):277-80. PubMed ID: 15944022
[TBL] [Abstract][Full Text] [Related]
10. Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests.
Bartfai T; Lu X; Badie-Mahdavi H; Barr AM; Mazarati A; Hua XY; Yaksh T; Haberhauer G; Ceide SC; Trembleau L; Somogyi L; Kröck L; Rebek J
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10470-5. PubMed ID: 15240875
[TBL] [Abstract][Full Text] [Related]
11. Galnon, a galanin receptor agonist, improves intrinsic cortical bone tissue properties but exacerbates bone loss in an ovariectomised rat model.
McGowan HW; Schuijers JA; Grills BL; McDonald SJ; McDonald AC
J Musculoskelet Neuronal Interact; 2014 Jun; 14(2):162-72. PubMed ID: 24879020
[TBL] [Abstract][Full Text] [Related]
12. Regulation of kindling epileptogenesis by hippocampal galanin type 1 and type 2 receptors: The effects of subtype-selective agonists and the role of G-protein-mediated signaling.
Mazarati A; Lundström L; Sollenberg U; Shin D; Langel U; Sankar R
J Pharmacol Exp Ther; 2006 Aug; 318(2):700-8. PubMed ID: 16699066
[TBL] [Abstract][Full Text] [Related]
13. Galanin: an endogenous anticonvulsant?
Mazarati A; Langel U; Bartfai T
Neuroscientist; 2001 Dec; 7(6):506-17. PubMed ID: 11765128
[TBL] [Abstract][Full Text] [Related]
14. GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
Lu X; Roberts E; Xia F; Sanchez-Alavez M; Liu T; Baldwin R; Wu S; Chang J; Wasterlain CG; Bartfai T
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15229-34. PubMed ID: 20660766
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of a new chimeric ligand for galanin receptors: galanin(1-13)-[D-Trp(32)]-neuropeptide Y(25-36)amide.
Saar K; Mahlapuu R; Laidmäe E; Valkna A; Kahl U; Karelson E; Langel U
Regul Pept; 2001 Oct; 102(1):15-9. PubMed ID: 11600206
[TBL] [Abstract][Full Text] [Related]
16. The role of galanin receptors in anticonvulsant effects of low-frequency stimulation in perforant path-kindled rats.
Sadegh M; Mirnajafi-Zadeh J; Javan M; Fathollahi Y; Mohammad-Zadeh M; Jahanshahi A; Noorbakhsh SM
Neuroscience; 2007 Dec; 150(2):396-403. PubMed ID: 17993248
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory control of the cough reflex by galanin receptors in the caudal nucleus tractus solitarii of the rabbit.
Mutolo D; Cinelli E; Bongianni F; Pantaleo T
Am J Physiol Regul Integr Comp Physiol; 2014 Dec; 307(11):R1358-67. PubMed ID: 25274905
[TBL] [Abstract][Full Text] [Related]
18. Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.
Robertson CR; Scholl EA; Pruess TH; Green BR; White HS; Bulaj G
J Med Chem; 2010 Feb; 53(4):1871-5. PubMed ID: 20121116
[TBL] [Abstract][Full Text] [Related]
19. Multiple interaction sites of galnon trigger its biological effects.
Florén A; Sollenberg U; Lundström L; Zorko M; Stojan J; Budihna M; Wheatley M; Martin NP; Kilk K; Mazarati A; Bartfai T; Lindgren M; Langel U
Neuropeptides; 2005 Dec; 39(6):547-58. PubMed ID: 16297447
[TBL] [Abstract][Full Text] [Related]
20. In vivo interaction between serotonin and galanin receptors types 1 and 2 in the dorsal raphe: implication for limbic seizures.
Mazarati AM; Baldwin RA; Shinmei S; Sankar R
J Neurochem; 2005 Dec; 95(5):1495-503. PubMed ID: 16219029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
